Omnicell, Inc. (OMCL) stock analysis
OMCL · Omnicell, Inc.
Latest recorded price: USD 35.44
Model-estimated fair value: USD 17.15. This assumption-based estimate is for general research and is not investment advice.
Sector and industry: Healthcare · Health Information Services
At $35.44, OMCL trades 106.6% above the model's base-case value of $17.15. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $15.12 in the conservative case and $18.81 in the optimistic case, with a valuation confidence score of 65/100. Fiscal 2025 figures: revenue growth -2.9%, free cash flow margin 7.3%, ROIC 0.4%. The model flags 1 risk signal for this company.